Document type: Toolkit Practice area: Corporate — Employee Benefits Jurisdiction: United States (federal) Last reviewed: 5 September 2026
How to use this toolkit
Every ESOP dispute reduces to one question: did the plan pay no more than fair market value, determined in good faith by a prudent trustee?
The transaction is a prohibited transaction under 29 U.S.C. § 1106 unless the exemption in § 1108(e) applies, and that exemption's condition is adequate consideration — defined in 29 U.S.C. § 1002(18) as fair market value determined in good faith by the trustee.
So the tools below are mostly about process and documentation. The price will be contested by experts years later; the process is established by contemporaneous documents or not at all.
Tool 1 — Feasibility model
ESOP FEASIBILITY — [Company] — [Date] — Prepared by [independent]
HISTORICAL (10 years)
Revenue | EBITDA | EBITDA margin | Capex | Working capital swing
10-yr revenue CAGR: ____% Worst 2-yr period: ______ (____%)
THREE CASES
Mgmt plan | Base | ** DOWNTURN **
Revenue growth ____% | ____%| ____%
EBITDA margin ____% | ____%| ____%
Year 1 EBITDA $_____ |$_____| $_____
Year 3 EBITDA $_____ |$_____| $_____
[Downturn = calibrated to the company's OWN worst 2-year period]
DEBT SERVICE TEST (each case)
Senior debt $_____ Rate ____ Amort ____ yrs
Seller note $_____ Rate ____ Amort ____ yrs
Annual debt service $_____
** PLUS ESOP contributions to service the internal loan ** $____
[Deductible under 26 U.S.C. § 404(a)(9) — but still CASH]
PLUS maintenance capex $_____
Total cash requirement $_____
Available cash flow $_____
** COVERAGE ____x | ____x | ____x **
** Covenant breach in the downturn case? Y / N **
If Y → the leverage is too high. Full stop.
QUALITATIVE
[ ] Revenue recurring and diversified? Top 3 customers ____%
[ ] Working capital swings manageable?
[ ] Business survives the owner's departure?
Customers who would leave: ______________
Transition completed: ______________
[ ] Management depth after the seller exits?
[ ] Functioning board? Independent directors?
[ ] 20-year repurchase obligation modeled? Peak year $______
PREPARED BY: ____________
** Success fee if the transaction closes? Y / N **
If Y — independent second look commissioned? [ ]
MAXIMUM SUPPORTABLE PRICE: $__________
Annotation. Two boxed lines carry this tool. The downturn covenant test is the one that should stop a bad transaction, and it is the test most feasibility studies omit or soften. And the preparer's success-fee disclosure is there because a study prepared by the firm that earns a fee on closing is not independent — a fact the seller is entitled to know before the price expectation is set.
Tool 2 — Exit comparison memorandum
MEMORANDUM TO [SELLER] — EXIT ALTERNATIVES — [Date]
| ESOP | Strategic sale | Sponsor recap
--------------------|------|----------------|---------------
Likely price | FMV | FMV + synergy | FMV, leveraged
| | premium |
Cash at closing | ___% | ___% | ___%
Deferred/at risk | ___% | ___% | ___%
Tax treatment |§1042 | current gain | partial defer
|defer | |
Diligence exposure | plan | ** COMPETITOR**| sponsor
Continuity of place | high | low | medium
Continuity of people| high | low | medium
Timeline |12-18m| 6-12m | 6-12m
Ongoing obligations |ERISA,| none | none
|repur-| |
|chase | |
WHAT AN ESOP DOES BETTER
· Liquidity at FMV without a competitor seeing the customer list
· § 1042 deferral (C corporation seller, plan holds ≥ 30%)
· Business stays where it is, with the people who run it
· Tax-exempt operating structure if S status follows
· A genuine employee benefit
WHAT IT DOES WORSE — STATE THESE PLAINLY
· FMV, NOT a strategic premium. A synergistic buyer can pay more
· The company takes on real debt, serviced from cash flow
· A permanent repurchase obligation
· ERISA: annual valuations, testing, administration, fiduciary
exposure
· Transaction costs in the high six figures; recurring annual
costs thereafter
· ** Your liquidity is largely a subordinated note secured by
nothing but the business you just sold, behind a bank **
WHEN AN ESOP DOES NOT WORK
Volatile or thin cash flow · heavy customer concentration ·
owner-dependent revenue · a seller who wants the maximum number
Seller acknowledgment: ______________ Date: ________
Annotation. The signature line is the point of the document. ESOPs are promoted energetically and sellers frequently arrive having heard only the tax deferral. A signed comparison that states the strategic-premium tradeoff and the credit risk of the seller note protects the seller from a decision made on incomplete information — and protects counsel from the conversation that follows a disappointing outcome.
Tool 3 — Role and engagement map
WHO REPRESENTS WHOM — [Transaction]
Party | Counsel | Retained by | Duty runs to
---------------------|--------------|-------------|--------------
Company | | Company | Company
Board (as APPOINTING | | | Plan
FIDUCIARY) | | | participants
Seller | | Seller | Seller
Trustee | | ** TRUSTEE**| Participants
Appraiser | n/a | ** TRUSTEE**| Trustee
Financial advisor | n/a | Trustee | Trustee
Lender | | Lender | Lender
** DEFECTS TO CONFIRM ARE ABSENT **
[ ] The founder's long-time lawyer is NOT drafting the plan,
advising the board, and negotiating for the seller
[ ] No advisor originated the deal, wrote the feasibility study,
recommended the trustee, AND earns a success fee
[ ] The appraiser has NOT valued this company for the seller's
estate planning
[ ] Trustee's counsel is a DIFFERENT FIRM with no prior
relationship to the seller
[ ] The seller did NOT select the trustee or the appraiser
ENGAGEMENT LETTERS — each states whom the firm represents:
[ ] Company counsel [ ] Seller's counsel [ ] Trustee's counsel
[ ] Appraiser (engaged BY the trustee)
Annotation. This one page is the first thing an investigator asks for and the last thing most transactions produce. Every item in the defects box is a pattern the Department of Labor has pursued, and every one of them is avoidable at the cost of a slightly larger fee. Complete it at the start, not at closing.
Tool 4 — Trustee selection questionnaire
INDEPENDENT TRUSTEE — SELECTION — [Company]
CAPACITY AND EXPERIENCE
1. ESOP transactions completed in the last 3 years: ______
In our industry: ______ At our size: ______
2. ** How many proposed transactions have you DECLINED, and
why? ** ______________________
3. Individuals who will staff this engagement — names,
experience, and time commitment: ______________
4. Do you serve as ongoing trustee after closing? Terms: ______
INDEPENDENCE
5. Any prior or current relationship with the seller, the
company, its counsel, or its advisors? ______
6. How do you select counsel and the appraiser? Describe the
process. ______________________
7. Fee structure — is any part contingent on closing? ______
** A contingent trustee fee is a conflict. **
PROCESS
8. Describe your diligence scope.
9. How do you test management projections?
10. Describe your negotiation practice. Do you make an opening
position below the seller's expectation?
11. How are deliberations documented?
12. Do you obtain a fairness opinion? From whom?
RISK
13. Fiduciary liability coverage: carrier, limits, exclusions.
14. Any DOL investigation or litigation involving your ESOP
transactions in the last 5 years? ______
REFERENCES: 3, chosen by us: ______________
Annotation. Question 2 is the one that distinguishes trustees. A firm that has never declined a transaction has either extraordinary luck or a business model. Question 7 matters for the same reason: a trustee whose fee depends on the deal closing is a fiduciary with a financial interest in saying yes, which is precisely the structure the exemption is meant to prevent.
Tool 5 — Appraiser engagement and independence
APPRAISER ENGAGEMENT — KEY TERMS
RETENTION
The Appraiser is engaged by, and reports solely to, ** THE
TRUSTEE **, in its capacity as fiduciary of the Plan. The
Company pays the fee. The Company and the Seller are not
clients and shall not direct the engagement.
SCOPE
Determine the fair market value of [securities], on a
[control/minority] basis, as of [date], for purposes of the
Trustee's determination of adequate consideration under
29 U.S.C. §§ 1002(18) and 1108(e).
INDEPENDENCE REPRESENTATIONS
[ ] No prior engagement by the Seller or the Company (or
disclose): ______________
[ ] No contingent fee
[ ] No interest in the transaction closing
[ ] Qualifications: credentials, ESOP experience, industry
DELIVERABLES
[ ] Draft report to the Trustee only
[ ] Final report addressed to the Trustee
[ ] Support for the annual valuation obligation under
26 U.S.C. § 401(a)(28)(C) going forward, if engaged
COMMUNICATIONS PROTOCOL
** All communications through the Trustee or its counsel.
No communication with the Seller or Seller's advisors
regarding value, drafts, or expectations. **
METHODOLOGY TO ADDRESS
[ ] DCF / guideline public company / guideline transaction
[ ] Control vs. minority basis, and why
[ ] Marketability discount, adjusted for repurchase obligation
and put right
[ ] Transaction debt
[ ] ** Warrants and other synthetic equity — valued and
reflected in the price **
[ ] S corporation tax benefit, if conversion is contemplated
Annotation. The communications protocol is the provision sellers violate. A phone call from the seller's advisor to the appraiser about "where we need to land" converts an independent valuation into a negotiated one, and it will surface in discovery. Put the protocol in the engagement letter and tell the seller's team about it in writing.
Tool 6 — Projection testing worksheet
TESTING MANAGEMENT'S PROJECTIONS — [Company]
TRACK RECORD
Year | Projected revenue | Actual | Variance | Projected EBITDA |
Actual | Variance
[last 5 years of prior projections vs. outcomes]
** Average forecast error: ____% revenue, ____% EBITDA **
GROWTH
Projected CAGR: ____% 10-yr historical CAGR: ____%
Industry growth rate: ____% Source: ______
** Gap explained by: ______________________ **
Is the explanation supported by contracts, backlog, or capacity?
MARGIN
Projected margin year 5: ____% Historical high: ____%
Basis for expansion: ______________________
[price increases? mix? volume leverage? cost program?]
Has a similar expansion been achieved before? Y / N
PIPELINE
Projected new revenue: $______
Under contract: $______ Verbal/LOI: $______ Hoped: $______
** Ratio of contracted to projected: ____% **
CONCENTRATION
Top 3 customers: ____% of revenue Top 10: ____%
Contract terms and renewal dates: ______________
Any at risk on the owner's departure? ______
CAPACITY AND INVESTMENT
Does the plan require capex the model does not fund? ______
CONCLUSION
Projections: [ ] adopted [ ] adjusted to: ______
Adjustments and basis: ______________________
Annotation. The track-record table at the top is the highest-value five minutes in the entire diligence. Management teams forecast optimistically and remember selectively; the record of past projections against outcomes is objective, available, and rarely requested. A trustee that documents an average forecast error and adjusts accordingly has done the thing prudence requires.
Tool 7 — Diligence request list (trustee side)
TRUSTEE DILIGENCE REQUEST — [Company]
FINANCIAL
5 years audited/reviewed financials · monthly management
accounts · budget vs. actual · aged receivables and payables ·
inventory analysis · capex history and plan · debt schedule ·
off-balance-sheet obligations · related party transactions
REVENUE AND CUSTOMERS
Revenue by customer, 5 years · top 20 customer contracts ·
concentration analysis · churn history · pipeline with
contracted vs. prospective · pricing history · backlog
OPERATIONS
Facilities and leases · equipment condition and age ·
capacity utilization · supplier concentration and contracts ·
quality and warranty history
PEOPLE
Organization chart · key employee agreements and retention ·
compensation study · ** dependence on the seller: which
relationships, which decisions ** · succession plan · union
status and CBAs
LEGAL
Litigation, pending and threatened · regulatory compliance and
history · environmental reports · insurance and claims history ·
IP schedule and ownership · material contracts · change of
control provisions
BENEFITS
Existing plans · funding status · any prior ESOP or ownership
arrangements
THE TRANSACTION
Feasibility study AND who prepared it · prior valuations and
who commissioned them · prior offers or LOIs received ·
seller's price expectation and its basis · advisor fee
arrangements including contingencies
Annotation. The last block is the one that distinguishes a trustee's diligence from a buyer's. Prior valuations commissioned by the seller, prior third-party offers, and advisor fee contingencies are all directly relevant to whether the price being proposed is fair market value — and none of them appears on a standard M&A request list.
Tool 8 — Negotiation log
NEGOTIATION RECORD — [Transaction]
Date | From | To | Price | Structure | Basis / analysis | Response
-----|------|----|-------|-----------|------------------|----------
| Trustee | Seller | $___ | ___ | [diligence finding
| | | | | supporting this position]
| Seller | Trustee| $___ | ___ | [seller's basis]
...
FINAL: $__________ Structure: ______________________
SUMMARY OF MOVEMENT
Trustee opening: $______ → Final: $______ (____%)
Seller opening: $______ → Final: $______ (____%)
FINDINGS THAT DROVE ADJUSTMENTS
1. [e.g., customer concentration at 44% vs. 36% presented]
→ effect on value: ______
2. [e.g., projected growth 6.5% vs. 2.4% historical]
→ effect on value: ______
TRUSTEE'S BASIS FOR THE FINAL DETERMINATION
______________________________________________________
** A transaction with no negotiation history is the pattern
regulators look for first. This log IS the defense. **
Annotation. Keep this log on both sides. Its purpose is not the price; it is the demonstration that a fiduciary formed an independent view, tested it against evidence, and moved for stated reasons. A trustee that accepted the asking price has a valuation report; a trustee with this log has a record of having made a determination.
Tool 9 — Warrant and section 409(p) worksheet
WARRANTS AND SYNTHETIC EQUITY — ** RUN BEFORE FINALIZING TERMS **
WARRANT TERMS UNDER DISCUSSION
Coverage: ____% of fully diluted equity
Strike: $______ Term: ____ years Vesting: ______
Holder: [seller / note holders]
VALUATION EFFECT
[ ] Warrants valued by the TRUSTEE's appraiser
[ ] Value: $______ Method: ______
[ ] ** Reflected in the purchase price? ** Y / N
[A warrant that transfers too much future value means the
plan effectively paid more than the stated price.]
Blended seller return with warrants: ____%
Market return for comparable subordinated risk: ____%
** SECTION 409(p) — S CORPORATION ANTI-ABUSE **
Will the company elect S status? Y / N When: ______
If Y:
[ ] Warrants are SYNTHETIC EQUITY for § 409(p) purposes
[ ] Disqualified persons identified: ______________
[ ] Deemed-owned shares + synthetic equity computed
[ ] ** Nonallocation year test run: PASS / FAIL **
[ ] Headroom under the test: ______
[ ] Other synthetic equity included: options, phantom stock,
SARs, deferred comp: ______________
[ ] Annual monitoring process established
CONSEQUENCES OF A NONALLOCATION YEAR: excise tax, potential
loss of the structure. ** This is why the analysis precedes
the term sheet, not the closing. **
SEQUENCING CONFIRMED
1. § 409(p) analysis → 2. Warrant terms → 3. Price
confirmation → 4. Documentation
Annotation. The sequencing box at the bottom exists because reversing it is the most common structural error in these transactions. Warrant coverage gets negotiated as a deal point, documents get drafted, and then someone runs the anti-abuse test and discovers the agreed structure produces a nonallocation year. Reopening an agreed economic term late is painful; running a test early is not.
Tool 10 — Section 1042 election checklist
SECTION 1042 ELECTION — [Seller]
ELIGIBILITY
[ ] Company is a ** C CORPORATION ** at closing
(existing S corporation? revocation timing: ______;
built-in gains consequences modeled: ______)
[ ] Securities held ≥ 3 years before the sale
[ ] Securities are not received in a distribution from a
qualified plan or through certain option exercises
[ ] ** Plan owns ≥ 30% of outstanding stock immediately after
the sale ** — computed: ____%
QUALIFIED REPLACEMENT PROPERTY
[ ] Strategy arranged with the seller's investment advisor
** BEFORE closing **
[ ] Replacement period: 3 months before → 12 months after sale
[ ] QRP = securities of domestic operating corporations meeting
the passive income and asset tests
[ ] Purchase dates and amounts tracked: ______________
[ ] Basis reduction understood (deferral, not exclusion)
FILINGS
[ ] Statement of election with the seller's return
[ ] Verified written statement of consent from the company
[ ] Statement from the seller of purchase of QRP
[ ] Notarization/timing requirements met
ALLOCATION RESTRICTIONS
[ ] Seller, family members, and >25% shareholders generally
cannot receive allocations of the § 1042 shares
[ ] Plan document reflects the restriction
[ ] Effect on the seller's own employees/family understood and
communicated
DISPOSITION OF QRP
[ ] Seller advised: disposing of QRP triggers recognition
[ ] Estate planning consequence noted (basis step-up at death)
Annotation. The bracketed allocation restriction is the item that surprises sellers with children in the business. A seller who elects § 1042 generally cannot have the deferred shares allocated to family members' accounts — so a founder whose daughter is the chief operating officer must weigh the deferral against her participation. Raise it before the election, not after.
Tool 11 — Fiduciary role map and insurance confirmation
FIDUCIARY ROLE MAP — [Company] — as of [date]
Function | Fiduciary? | Who | Appointed by |
Monitored by | Insured under
----------------------------|------------|-----|--------------|
Appointing the trustee | YES |Board| (charter) |
Monitoring the trustee | YES |Board| |
Holding/voting plan assets | YES |Trustee| Board |
Determining adequate | YES |Trustee| |
consideration | | | |
Selecting the appraiser | YES |Trustee| |
Plan administration | YES |Committee| Board |
Eligibility/allocations | YES |Committee| |
Distribution decisions | YES |Committee| |
Claims determinations | YES |Committee| |
Running the business | NO |Mgmt | |
Setting compensation | NO* |Board| *unless plan
| | | assets involved
INSURANCE — CONFIRM BOTH EXIST
[ ] ** FIDELITY BOND ** — 29 U.S.C. § 1112. MANDATORY.
Protects the PLAN against fraud or dishonesty.
Amount: $______ (≥10% of funds handled, within limits)
Carrier: ______ Covers every person handling plan funds: []
[ ] ** FIDUCIARY LIABILITY INSURANCE ** — protects FIDUCIARIES
against breach claims. NOT the same thing.
Carrier: ______ Limits: $______ Exclusions: ______
Named/covered fiduciaries: ______________
INDEMNIFICATION — 29 U.S.C. § 1110
[ ] No provision purports to RELIEVE a fiduciary of liability
(void)
[ ] EMPLOYER indemnification of fiduciaries — permitted: []
[ ] ** PLAN indemnification — NOT permitted ** — confirmed
absent from plan, charter, bylaws, and trustee engagement
ANNUAL HAT-CHECK: circulated ______ Confirmations received ______
Annotation. The two insurance lines are separated because companies routinely have the mandatory bond, believe it is fiduciary coverage, and discover otherwise when a claim arrives. The bond protects the plan against theft; it does nothing for a director facing a prudence claim under 29 U.S.C. § 1109. Confirm both, name the covered persons, and check the exclusions.
Tool 12 — Repurchase obligation model and annual calendar
REPURCHASE OBLIGATION MODEL — refresh every 2-3 years
INPUTS
Participant census by age and service
Turnover by cohort (historical, 5 years)
Retirement age assumptions
Share allocation schedule (internal loan amortization)
Share value growth assumption: ____%
Distribution timing per plan document
Diversification elections: 26 U.S.C. § 401(a)(28)(B) —
qualified participants at 55 with 10 years
OUTPUT — 25-year projection
Year | Distributions triggered | Shares | $ obligation |
Cumulative | As % of EBITDA
** PEAK YEAR: ______ PEAK OBLIGATION: $______ **
FUNDING STRATEGY — choose deliberately
[ ] Operating cash [ ] Sinking fund
[ ] Corporate-owned life insurance
[ ] ** RECYCLING ** (plan repurchases with contributions —
share count constant)
[ ] ** REDEMPTION ** (company repurchases — share count falls,
per-share value rises, NEXT cohort's balances rise)
Policy documented: [ ]
PLAN DESIGN LEVERS
[ ] Distribution timing within statutory limits
[ ] Installment payment where permitted
[ ] Vesting schedule
ANNUAL COMPLIANCE CALENDAR
Q1 [ ] Independent appraisal engaged (26 U.S.C. § 401(a)(28)(C))
[ ] Prior-year census and payroll data to recordkeeper
Q2 [ ] Valuation received; ** committee reviews and documents **
[ ] Coverage and nondiscrimination testing
[ ] ** § 409(p) testing (S corporations) — incl. ALL
synthetic equity **
Q3 [ ] Form 5500 filed
[ ] Participant statements issued
[ ] Annual meeting: valuation presented and explained
Q4 [ ] Fidelity bond and fiduciary insurance renewed/confirmed
[ ] Committee minutes reviewed for the year
[ ] ** Appointing fiduciary's annual trustee review **
[ ] Fiduciary role map circulated (hat-check)
Biennial/triennial
[ ] Repurchase obligation study refreshed
Annotation. The peak-year output is the number that should be on the board's radar from closing. A leveraged ESOP feels comfortable for fifteen years and then meets the retirement of the cohort hired around the transaction — holding accounts that reflect two decades of appreciation — in the same years the company's own capital needs are highest. Companies that model the peak early choose a funding strategy; companies that do not borrow to pay retirees.
Tool 13 — Employee communication outline and DOL response index
EMPLOYEE COMMUNICATION — TRANSACTION ANNOUNCEMENT
1. WHAT HAPPENED
[Seller] sold [__]% of the company to a retirement plan that
holds stock for employees.
2. ** WHAT YOU RECEIVE **
· An account in a retirement plan
· Shares credited to it over time as the plan's loan is repaid
· Vesting after ____ years
· Value set annually by an independent appraiser
· Paid in CASH when you leave, under a put right
(26 U.S.C. § 409(h))
3. ** WHAT YOU DO NOT RECEIVE **
· Stock you can sell
· A dividend you can spend
· A seat on the board
· A vote on ordinary company decisions
[Pass-through voting only on major events — 26 U.S.C.
§ 409(e): merger, sale of substantially all assets,
liquidation]
4. ** WHY YOUR FIRST STATEMENTS WILL LOOK SMALL **
Shares are released as the loan is repaid. Balances build over
[__] years.
5. ** WHY THE FIRST VALUATION MAY BE LOWER THAN THE SALE PRICE **
The company borrowed to fund the purchase. Debt reduces value
until it is repaid.
6. WHAT HAPPENS NEXT
Annual valuation · annual meeting · statements · questions to
[named contact, NOT the seller]
REVIEWED BY COUNSEL: [ ] RETAINED: [ ]
[Enthusiastic "ownership" messaging becomes an exhibit.]
DOL RESPONSE FILE INDEX — assemble at closing, not at inquiry
1. Feasibility study, and who prepared it (fee contingency?)
2. Exit comparison memorandum, signed by the seller
3. Role and engagement map; all engagement letters
4. Trustee selection: RFP, questionnaires, board resolution
(with seller recused)
5. Trustee's counsel engagement
6. Appraiser selection process and engagement letter
7. Diligence request list and materials produced
8. ** Projection testing worksheet **
9. Valuation report(s), draft and final
10. ** Negotiation log **
11. Trustee deliberative minutes
12. Fairness opinion
13. Warrant valuation and § 409(p) analysis
14. Transaction documents
15. § 1042 election documents
16. Fiduciary role map; bond and insurance certificates
17. Employee communications
18. Annual valuations, minutes, testing, and Form 5500s since
Annotation. Assemble the response index at closing. The investigation, if it comes, will arrive years later, after the people involved have left and the files have moved — and the difference between a short inquiry and a long one is whether items 4, 6, 8, 10, and 11 exist. The price is contested by experts; the process is proved by documents created at the time or not at all.
Related documents
- Employee Stock Ownership Plans: Valuation, Fiduciary Duty, and the Leveraged ESOP Transaction
- Selling a Company to an ESOP: A Practical Guide
- ESOP Transaction and Fiduciary Checklist: A Practical Checklist
- ERISA Fiduciary Duties for Plan Sponsors and Committees
- Business Succession Planning Toolkit
- Corporate Governance Toolkit: Boards, Committees, and Fiduciary Process
This toolkit is general information, not legal advice, and does not create an attorney-client relationship.
